Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice | Italian Journal of Medicine

Current Issue

Vol. 7 No. s8 (2013)

24 December 2013

View this Issue

Impact Factor 2025

Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice

View Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice

Published: 24 December 2013

Reviews

Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

https://doi.org/10.4081/itjm.2013.s8.1

13785

PDF: 3236
- PDF
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

https://doi.org/10.4081/itjm.2013.s8.8

1543

PDF: 1070
- PDF
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

https://doi.org/10.4081/itjm.2013.s8.22

1192

PDF: 882
- PDF
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

https://doi.org/10.4081/itjm.2013.s8.29

1237

PDF: 983
- PDF
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

https://doi.org/10.4081/itjm.2013.s8.36

1108

PDF: 935
- PDF
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

https://doi.org/10.4081/itjm.2013.s8.41

1091

PDF: 954
- PDF
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

https://doi.org/10.4081/itjm.2013.s8.48

1619

PDF: 1125
- PDF
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

https://doi.org/10.4081/itjm.2013.s8.59

1111

PDF: 1052
- PDF
New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

Mauro Silingardi

65-70

https://doi.org/10.4081/itjm.2013.s8.65

1522

PDF: 1088
- PDF
The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise

Francesco Rodeghiero, Massimo Morfini, Carlo Nozzoli, Cesare Manotti, Francesco Violi, Giuseppe Castaldo, Fabrizio Pane, Bruno Biasioli, Claudio Velati, on behalf of SISET, AICE, FADOI, FCSA, SIBioC, SIE, SIMeL, SIMI, SIMTI

71-73

https://doi.org/10.4081/itjm.2013.s8.71

1563

PDF: 1031
- PDF
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

https://doi.org/10.4081/itjm.2013.s8.74

1457

PDF: 1032
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.